MCP Tips for better browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on January 1, 2008.
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700128-MCP200v1
7/1/71    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulintz, P. J.
Right arrow Articles by Nesvizhskii, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulintz, P. J.
Right arrow Articles by Nesvizhskii, A. I.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 23, 2007
Revised on September 12, 2007
Accepted on September 13, 2007

Investigating MS2-MS3 matching statistics: A model for coupling consecutive stage mass spectrometry data for increased peptide identification confidence

Peter J. Ulintz, Bernd Bodenmiller, Philip C. Andrews, Ruedi Aebersold, and Alexey I. Nesvizhskii

Pathology, University of Michigan Medical School, Ann Arbor, MI 48109

Corresponding Author: nesvi{at}med.umich.edu

Improvements in ion trap instrumentation have made n-dimensional mass spectrometry more practical. The overall goal of the study is to describe a model for making use of MS2 and MS3 information in mass spectrometry experiments. We present a statistical model for adjusting peptide identification probabilities based on the combined information obtained by coupling peptide assignments of consecutive MS2 and MS3 spectra. Using two data sets, a mixture of known proteins and a complex phosphopeptide-enriched sample, we demonstrate an increase in discriminating power of the adjusted probabilities, compared to models using MS2 or MS3 data only. This work also addresses the overall value of generating MS3 data as compared to an MS2-only approach, with a focus on the analysis of phosphopeptide data.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 BioinformaticsHome page
N. Bandeira, J. V. Olsen, M. Mann, and P. A. Pevzner
Multi-spectra peptide sequencing and its applications to multistage mass spectrometry
Bioinformatics, July 1, 2008; 24(13): i416 - i423.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.